Insight Pharma Affiliated Reports Collection Announces Biopharma Report

April 3, 2012 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Affiliated Reports Collection announces the Biopharma Outsourcing Performance Report, published by ISR Reports.

This report examines the outsourcing relationship from the CRO's perspective and benchmarks 53 sponsor companies' outsourcing operations and practices, as well as provides metrics for short, average, and extended timelines for critical stages in the outsourcing decision process.

Key features:

1. Positive Biopharma Performance
2. Turnaround Metrics
3. The Service Provider’s View
         •Delays in Patient Recruitment
         •Service Provider Selection Criteria
         •Selection Criteria Becoming More Important
         •Service Provider Differentiation

For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.